logo
  • Home
  • News
Menu

Inhaler maker Vectura snubs Philip Morris in favour of private equity bid

Home / Stock Analysis / Inhaler maker Vectura snubs Philip Morris in favour of private equity bid
Article feature image

Inhaler maker Vectura snubs Philip Morris in favour of private equity bid

06 Aug Stock Analysis

Inhaler maker Vectura has jumped ‘out of the frying pan, into the fire’ after it snubbed an offer from Philip Morris in favour of a private equity bid. 
Vectura, which specialises in making inhaled medicines, agreed to a 150p-per-share offer from the cigarette…

Click here to view the original article.

Tags:
featured, Global, This is Money
Facebook Google+ Twitter Pinterest
  Previous
Next  

Related Posts

ON20Semiconductor20Corp_20sign20in20Silicon20Valley-by20Sundry20Photography20via20Shutters.jpeg
+

What Are Wall Street Analysts’ Target Price for ON Semiconductor Stock?

03 Nov Stock Analysis
1762180540_articleshow.jpg
+

kenvue: Kenvue stock share price today: Kimberly-Clark to acquire Tylenol maker Kenvue for $40 billion in cash and stock deal. Here’s background, current challenges, future outlook, market reaction

03 Nov Stock Analysis

recent post

  • 1-6.jpg

    BlockchainFX Leads the Best Crypto Presales

    Nov 03 2025
  • JA_Canada_Strategic_Partnerships_Fuel_JA_Canada_s_Renewal_of_Inv.jpg

    Strategic Partnerships Fuel JA Canada’s Renewal

    Nov 03 2025
  • 6908cb34c833a5c967127a24_6908cb33bd7edf0f6ac491b2_lastImage.png

    Unlocking Financial Freedom: The Ultimate Guide

    Nov 03 2025
  • 720_Paisley_Nardini_Speaker_Card.png

    Portfolio Diversification with Paisley Nardini

    Nov 03 2025
  • ae853a0ab8900517aefe4e8863bc367a2aa75dda-1920x1080.jpg

    Donut Labs Raises $15M Seed Funding

    Nov 03 2025

Categories

  • Business
  • Crypto News
  • Investing Strategy
  • People
  • Stock Analysis

©2019.  All Rights Reserved.